Nothing is perfect. That can certainly be said for the comprehensive front-page article the New York Times ran this Saturday, April 5, on the high cost of new type 1 diabetes tools. While the story was one of the best we’ve seen in describing the challenges of insulin dependence and the huge cost barriers that exist for patients in our convoluted American healthcare system, some felt that it actually disses innovation in diabetes tools –…Read more »
Sorry, Mr. Pancreas, but your role in reversing type 1 diabetes could become irrelevant if the Diabetes Research Institute has anything to say about it.
Top diabetes researchers at the DRI plan to create a new mini-organ that would make the current efforts to transplant islet cells from a donated pancreas and into a person’s liver a focus of the past.
Instead, the DRI is developing a small man-made receptacle that it’s calling the BioHub,…
Get ready for a slew of diabetes news announcements, because the ADA’s huge annual conference starts today!
I’ll be on an airplane pretty much all day (Friday) heading out to Orlando to cover this conference live, although I must warn you: it’s quite overwhelming. Running around the 450,000 square-foot convention center trying to see every diabetes company represented in the enormous exhibit halls while hundreds of symposia and other talk sessions are happening simultaneously is…Read more »
Are diabetes headlines in the mainstream media mostly a bunch of hype, or do they bring us real hope for the future? The panel I moderated on this topic at the Diabetes Research Institute’s annual conference in New York City last week produced quite a lively discussion. I referenced all of your comments as well, so thank you all, Dear Readers!
As Dr. Jay Skyler pointed out, there’s only one letter difference between HYPE and…
A call for YOUR pressing questions!
This coming Saturday, Oct. 25, is the Diabetes Research Institute’s annual conference in New York. One of the main topics is making sense of news coverage on diabetes — are the headlines all just a bunch of hype, or do they bring us real hope?
The DRI has asked me to publish a call for your questions here: if you were in a room with a panel of diabetes…